Results 71 to 80 of about 22,462 (308)
Background Extracellular vesicles (EVs) produced by human bone marrow-derived mesenchymal stromal cells (hBM-MSCs) are currently investigated for their clinical effectiveness towards immune-mediated diseases.
Jonathan Gobin+14 more
doaj +1 more source
Serotonergic modulators in Alzheimer's disease: a hope in the hopeless condition
Alzheimer disease (AD) is the main cause of dementia worldwide. AD is a progressive brain neurodegenerative disease due to genetic and environmental factors that induce a progressive accumulation of intracellular hyperphosphorylated tau protein and extracellular amyloid protein (Aβ).
Ali I. Al-Gareeb+5 more
wiley +1 more source
This study reports the synthesis of five tetrazine‐coordinated, half‐sandwich iridium complexes and extensively describe their reactivity. Live cell fluorescent bioorthogonal labeling reveals the nuclear tropism of the most cytotoxic complex. Intracellular imaging of anticancer metallodrugs often relies on prelabeling with organic fluorophores, which ...
Alfonso Annunziata+6 more
wiley +1 more source
Brain MRI-to-PET Synthesis using 3D Convolutional Attention Networks [PDF]
Accurate quantification of cerebral blood flow (CBF) is essential for the diagnosis and assessment of a wide range of neurological diseases. Positron emission tomography (PET) with radiolabeled water (15O-water) is considered the gold-standard for the measurement of CBF in humans. PET imaging, however, is not widely available because of its prohibitive
arxiv
Unconventional Nuclides for Radiopharmaceuticals
Rapid and widespread growth in the use of nuclear medicine for both diagnosis and therapy of disease has been the driving force behind burgeoning research interests in the design of novel radiopharmaceuticals. Until recently, the majority of clinical and basic science research has focused on the development of 11C-, 13N-, 15O-, and 18F ...
Jason S. Lewis+2 more
openaire +4 more sources
Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR
Tumor heterogeneity is challenging for cancer diagnosis and treatment. This study designs and evaluates three gallium‐68 radiolabeled heterodimers targeting two G‐protein coupled receptors, namely NTS1 (neurotensin receptor 1) and GRPR (gastrin‐releasing‐peptide receptor). The branched analogue [68Ga]Ga‐JMV 7266 preserves NTS1 affinity, exhibits higher
Sacha Bodin+9 more
wiley +1 more source
The overexpression of cholecystokinin B receptor (CCKBR) in human cancers led to the development of radiolabeled minigastrin analogues for targeted radionuclide therapy, which aims to deliver cytotoxic radiation specifically to cancer cells.
Yun Qin+6 more
doaj +1 more source
By N‐methylation, the intramolecular lactam formation in carborane‐substituted diclofenac analogs is prevented, yielding a series of open‐chain derivatives alongside with their phenyl analogs exhibiting anticancer activity and thus offering a promising avenue for future drug development. This study explores the anticancer potential of N‐methylated open‐
Christoph Selg+12 more
wiley +1 more source
Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu nuclear reaction
Background There are only a handful of true theranostic matched pairs, and in particular the theranostic radiocopper trio 61Cu, 64Cu and 67Cu, for diagnosis and therapy respectively, is a very attractive candidate. In fact, the alternative of two imaging
Santiago Andrés Brühlmann+3 more
doaj +1 more source
Radiopharmaceuticals in Acute Porphyria
The acute porphyrias are a group of rare metabolic disorders of the heme biosynthetic pathway. Carriers of the acute porphyria gene are prone to potentially fatal acute attacks, which can be precipitated by drug exposure. It is therefore important to know whether a drug is safe for carriers of the acute porphyria gene.
Nanno Schreuder+2 more
openaire +3 more sources